| 2016 update of the EULAR recommendations for the management of early arthritis B Combe, R Landewe, CI Daien, C Hua, D Aletaha, JM Álvaro-Gracia, ... Annals of the rheumatic diseases 76 (6), 948-959, 2017 | 730 | 2017 |
| Methotrexate and lung disease in rheumatoid arthritis: a meta‐analysis of randomized controlled trials R Conway, C Low, RJ Coughlan, MJ O'Donnell, JJ Carey Arthritis & rheumatology 66 (4), 803-812, 2014 | 293 | 2014 |
| JAK inhibitors in rheumatoid arthritis: an evidence-based review on the emerging clinical data R Harrington, SA Al Nokhatha, R Conway Journal of inflammation research, 519-531, 2020 | 215 | 2020 |
| Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry PM Machado, S Lawson-Tovey, A Strangfeld, EF Mateus, KL Hyrich, ... Annals of the rheumatic diseases 81 (5), 695-709, 2022 | 192 | 2022 |
| COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations R Grainger, AHJ Kim, R Conway, J Yazdany, PC Robinson Nature Reviews Rheumatology 18 (4), 191-204, 2022 | 172 | 2022 |
| Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey SE Sattui, JW Liew, K Kennedy, E Sirotich, M Putman, TT Moni, A Akpabio, ... RMD open 7 (3), e001814, 2021 | 167 | 2021 |
| Risk of liver disease in methotrexate treated patients R Conway, JJ Carey World Journal of Hepatology 9 (26), 1092, 2017 | 166 | 2017 |
| EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update RBM Landewé, FPB Kroon, A Alunno, A Najm, JWJ Bijlsma, ... Annals of the rheumatic diseases 81 (12), 1628-1639, 2022 | 160 | 2022 |
| Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised … R Conway, C Low, RJ Coughlan, MJ O’Donnell, JJ Carey bmj 350, 2015 | 155 | 2015 |
| SARS–CoV‐2 infection and COVID‐19 outcomes in rheumatic diseases: a systematic literature review and meta‐analysis R Conway, AA Grimshaw, MF Konig, M Putman, A Duarte‐García, ... Arthritis & Rheumatology 74 (5), 766-775, 2022 | 154 | 2022 |
| Methotrexate-associated pneumonitis and rheumatoid arthritis-interstitial lung disease: current concepts for the diagnosis and treatment GE Fragoulis, E Nikiphorou, J Larsen, P Korsten, R Conway Frontiers in medicine 6, 238, 2019 | 143 | 2019 |
| Association between tumor necrosis factor inhibitors and the risk of hospitalization or death among patients with immune-mediated inflammatory disease and COVID-19 Z Izadi, EJ Brenner, SK Mahil, N Dand, ZZN Yiu, M Yates, RC Ungaro, ... JAMA network open 4 (10), e2129639-e2129639, 2021 | 126 | 2021 |
| Ustekinumab for the treatment of refractory giant cell arteritis R Conway, L O'Neill, E O'Flynn, P Gallagher, GM McCarthy, CC Murphy, ... Annals of the rheumatic diseases 75 (8), 1578-1579, 2016 | 114 | 2016 |
| Ustekinumab for refractory giant cell arteritis: a prospective 52-week trial R Conway, L O'Neill, P Gallagher, GM McCarthy, CC Murphy, DJ Veale, ... Seminars in arthritis and rheumatism 48 (3), 523-528, 2018 | 110 | 2018 |
| Risk of liver injury among methotrexate users: a meta-analysis of randomised controlled trials R Conway, C Low, RJ Coughlan, MJ O’Donnell, JJ Carey Seminars in arthritis and rheumatism 45 (2), 156-162, 2015 | 107 | 2015 |
| Risk of infection with methotrexate therapy in inflammatory diseases: a systematic review and meta-analysis A Ibrahim, M Ahmed, R Conway, JJ Carey Journal of clinical medicine 8 (1), 15, 2018 | 102 | 2018 |
| Methotrexate and interstitial lung disease: controversies and questions. A narrative review of the literature GE Fragoulis, R Conway, E Nikiphorou Rheumatology 58 (11), 1900-1906, 2019 | 101 | 2019 |
| Long-term outcome of an AMAU—a decade’s experience R Conway, D O’riordan, B Silke QJM: An International Journal of Medicine 107 (1), 43-49, 2014 | 96 | 2014 |
| Increased body mass index in ankylosing spondylitis is associated with greater burden of symptoms and poor perceptions of the benefits of exercise L Durcan, F Wilson, R Conway, G Cunnane, FD O’SHEA The Journal of rheumatology 39 (12), 2310-2314, 2012 | 89 | 2012 |
| Serum potassium levels as an outcome determinant in acute medical admissions R Conway, D Creagh, DG Byrne, D O’Riordan, B Silke Clinical Medicine 15 (3), 239-243, 2015 | 83 | 2015 |
Sean CournaneMedical Physicist, St Vincent's University HospitalПідтверджена електронна адреса в svuh.ie